Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1011320120050020087
Journal of Pharmacoepidemiology and Risk Management
2012 Volume.5 No. 2 p.87 ~ p.91
Standardization of the Criteria for Serious Adverse Event/Adverse Drug Reaction in Spontaneous Reporting: Korea Food and Drug Administration Pharmacovigilance Research Network Regional Pharmacovigilance Centers
Shin Hee-Young

Hong Chein-Soo
Park Byung-Joo
Kim Sang-Heon
Kim Cheol-Woo
Kim Tae-Bum
Park Young-Min
Park Hye-Kyung
Sohn Seong-Wook
Lee Byung-Jae
Lee Jae-Hyun
Koh Young-Il
Abstract
Objective: There have been no consistent criteria for serious adverse event (AE)/adverse drug reaction (ADR) in spontaneous reporting from Regional Pharmacovigilance Centers (RPVCs) in Korea. This study aimed to develop the standardization of the criteria for serious AE/ADR.

Methods: A task force team (TFT) was organized to make a draft for the standardized criteria for serious AE/ADR among the researchers of RPVCs. First, the current situations of serious AE/ADR reporting were reviewed, and then the first version of the standardized criteria for serious AE/ADR was prepared. After having feedbacks and discussions, the TFT made the revision. The revised standardization was reviewed again and finalized through the consensus of researchers.

Results: The questionnaire on the current criteria for serious AE/ADR in RPVCs revealed that each center had different detailed criteria or it did not have specific criteria. The standardized criteria for serious AE/ADR were proposed and modified through feedbacks and discussions. The criteria including detailed information on six conditions were finalized.

Conclusion: The standardization of the criteria for serious AE/ADR will help RPVCs report in a consistent way and improve the quality of spontaneous reporting data.
KEYWORD
Pharmacovigilance, Regional pharmacovigilance center, Serious adverse event, Adverse drug reaction, Standardization
FullTexts / Linksout information
Listed journal information